Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25552
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Froitzheim, Benjamin M W | - |
dc.contributor.author | Boktor, Raef R | - |
dc.contributor.author | Lau, Eddie | - |
dc.contributor.author | Lee, Sze Ting | - |
dc.date | 2020-07 | - |
dc.date.accessioned | 2021-01-04T23:56:35Z | - |
dc.date.available | 2021-01-04T23:56:35Z | - |
dc.date.issued | 2020-07-01 | - |
dc.identifier.citation | World Journal of Nuclear Medicine 2020; 19(3): 277-280 | en |
dc.identifier.issn | 1450-1147 | |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/25552 | - |
dc.description.abstract | This case report presents a patient with recurrent pleomorphic mantle cell lymphoma (MCL), which is a relatively rare but aggressive type of lymphoma. A positron emission tomography/computed tomography scan performed to assess treatment response demonstrated a complete metabolic response in the sites of primary disease while also revealing new subcutaneous lesions, which were biopsy-proven recurrent disease. This case illustrates the importance of the different biological behavior of MCL, whereby new sites of metabolically active lesions can represent recurrent disease, even though there is a complete metabolic response at sites of primary disease. | en |
dc.language.iso | eng | |
dc.subject | Fluorodeoxyglucose-positron emission tomography/computed tomography | en |
dc.subject | mantle cell lymphoma | en |
dc.subject | recurrent lymphoma | en |
dc.subject | treatment response | en |
dc.title | Unusual location of recurrent mantle cell lymphoma on fluorodeoxyglucose-positron emission tomography despite complete metabolic resolution of previous sites of disease. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | World Journal of Nuclear Medicine | en |
dc.identifier.affiliation | University of Regensburg, Regensburg, Germany | en |
dc.identifier.affiliation | Radiology | en |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Melbourne, Australia | en |
dc.identifier.affiliation | Molecular Imaging and Therapy | en |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en |
dc.identifier.affiliation | School of Cancer Medicine, LaTrobe University, Melbourne, Australia | en |
dc.identifier.doi | 10.4103/wjnm.WJNM_65_19 | en |
dc.type.content | Text | en |
dc.identifier.pubmedid | 33354186 | |
local.name.researcher | Lau, Eddie | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Radiology | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.